Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Contrasting selective patterns across the segmented genome of bluetongue virus in a global reassortment hotspot.

Jacquot M, Rao PP, Yadav S, Nomikou K, Maan S, Jyothi YK, Reddy N, Putty K, Hemadri D, Singh KP, Maan NS, Hegde NR, Mertens P, Biek R.

Virus Evol. 2019 Aug 5;5(2):vez027. doi: 10.1093/ve/vez027. eCollection 2019 Jul.

2.

Position Paper on Road Map for RNA Virus Research in India.

Medigeshi GR, Fink K, Hegde NR.

Front Microbiol. 2018 Jul 31;9:1753. doi: 10.3389/fmicb.2018.01753. eCollection 2018.

3.

Immunogenicity of a Candidate Ebola Hemorrhagic Fever Vaccine in Mice Based on Controlled In Vitro Expression of Ebolavirus Glycoprotein.

Kumar D, Gauthami S, Uma M, Nagalekshmi K, Rao PP, Basu A, Ella KM, Hegde NR.

Viral Immunol. 2018 Sep;31(7):500-512. doi: 10.1089/vim.2017.0122. Epub 2018 Aug 10.

PMID:
30095362
4.

A novel point mutation (L70P) inactivates poliovirus 3C protease.

Uma M, Hegde SR, Rao PP, Nagalekshmi K, Gauthami S, Kumar D, Hegde NR.

Acta Virol. 2018;62(1):68-77. doi: 10.4149/av_2018_108.

PMID:
29521105
5.
6.

The use of databases, data mining and immunoinformatics in vaccinology: where are we?

Hegde NR, Gauthami S, Sampath Kumar HM, Bayry J.

Expert Opin Drug Discov. 2018 Feb;13(2):117-130. doi: 10.1080/17460441.2018.1413088. Epub 2017 Dec 11. Review.

PMID:
29226722
7.

Isolation and evolutionary analysis of Australasian topotype of bluetongue virus serotype 4 from India.

Reddy YV, Susmitha B, Patil S, Krishnajyothi Y, Putty K, Ramakrishna KV, Sunitha G, Devi BV, Kavitha K, Deepthi B, Krovvidi S, Reddy YN, Reddy GH, Singh KP, Maan NS, Hemadri D, Maan S, Mertens PP, Hegde NR, Rao PP.

Transbound Emerg Dis. 2018 Apr;65(2):547-556. doi: 10.1111/tbed.12738. Epub 2017 Nov 9.

PMID:
29120083
8.

The use of BirA-BAP system to study the effect of US2 and US11 on MHC class I heavy chain in cells.

Gauthami S, Kumar D, SivaSai KSR, Hegde NR.

Immunol Lett. 2017 Oct;190:233-239. doi: 10.1016/j.imlet.2017.08.027. Epub 2017 Aug 30.

PMID:
28860039
9.

Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.

Hegde NR, Gore MM.

Hum Vaccin Immunother. 2017 Jun 3;13(6):1-18. doi: 10.1080/21645515.2017.1285472. Epub 2017 Feb 22. Review.

10.

Dual Infection with Bluetongue Virus Serotypes and First-Time Isolation of Serotype 5 in India.

Hemadri D, Maan S, Chanda MM, Rao PP, Putty K, Krishnajyothi Y, Reddy GH, Kumar V, Batra K, Reddy YV, Maan NS, Reddy YN, Singh KP, Shivachandra SB, Hegde NR, Rahman H, Mertens PPC.

Transbound Emerg Dis. 2017 Dec;64(6):1912-1917. doi: 10.1111/tbed.12589. Epub 2016 Dec 21.

PMID:
28004522
11.

Prevalence and genotype distribution of methicillin-resistant Staphylococcus aureus (MRSA) in India.

Sunagar R, Hegde NR, Archana GJ, Sinha AY, Nagamani K, Isloor S.

J Glob Antimicrob Resist. 2016 Dec;7:46-52. doi: 10.1016/j.jgar.2016.07.008. Epub 2016 Aug 28. Review.

PMID:
27598056
12.

Expression and purification of polioviral proteins in E. coli, and production of antisera as reagents for immunological assays.

Uma M, Rao PP, Nagalekshmi K, Hegde NR.

Protein Expr Purif. 2016 Dec;128:115-22. doi: 10.1016/j.pep.2016.08.014. Epub 2016 Aug 24.

13.

Isolation of Bluetongue Virus 24 from India - An Exotic Serotype to Australasia.

Krishnajyothi Y, Maan S, Kandimalla K, Maan NS, Tutika RB, Reddy YV, Kumar A, Mrunalini N, Reddy GH, Putty K, Ahmed SM, Reddy YN, Hemadri D, Singh KP, Mertens PP, Hegde NR, Rao PP.

Transbound Emerg Dis. 2016 Aug;63(4):360-4. doi: 10.1111/tbed.12512. Epub 2016 May 30.

PMID:
27241307
14.

Isolation, Biochemical and Molecular Identification, and In-Vitro Antimicrobial Resistance Patterns of Bacteria Isolated from Bubaline Subclinical Mastitis in South India.

Preethirani PL, Isloor S, Sundareshan S, Nuthanalakshmi V, Deepthikiran K, Sinha AY, Rathnamma D, Nithin Prabhu K, Sharada R, Mukkur TK, Hegde NR.

PLoS One. 2015 Nov 20;10(11):e0142717. doi: 10.1371/journal.pone.0142717. eCollection 2015. Erratum in: PLoS One. 2015;10(12):e0145897.

15.

Typing of Staphylococcus aureus isolated from bovine mastitis cases in Australia and India.

Gogoi-Tiwari J, Babra Waryah C, Sunagar R, Veeresh HB, Nuthanalakshmi V, Preethirani PL, Sharada R, Isloor S, Bhat A, Al-Salami H, Hegde NR, Mukkur TK.

Aust Vet J. 2015 Aug;93(8):278-82. doi: 10.1111/avj.12349.

PMID:
26220320
16.

Sero-Prevalence of Rodent Pathogens in India.

Manjunath S, Kulkarni PG, Nagavelu K, Samuel RJ, Srinivasan S, Ramasamy N, Hegde NR, Gudde RS.

PLoS One. 2015 Jul 9;10(7):e0131706. doi: 10.1371/journal.pone.0131706. eCollection 2015.

17.

Full-Genome Sequencing as a Basis for Molecular Epidemiology Studies of Bluetongue Virus in India.

Maan S, Maan NS, Belaganahalli MN, Rao PP, Singh KP, Hemadri D, Putty K, Kumar A, Batra K, Krishnajyothi Y, Chandel BS, Reddy GH, Nomikou K, Reddy YN, Attoui H, Hegde NR, Mertens PP.

PLoS One. 2015 Jun 29;10(6):e0131257. doi: 10.1371/journal.pone.0131257. eCollection 2015.

18.

Cell culture-based influenza vaccines: A necessary and indispensable investment for the future.

Hegde NR.

Hum Vaccin Immunother. 2015;11(5):1223-34. doi: 10.1080/21645515.2015.1016666. Review.

19.

Genome Sequence of Bluetongue Virus Type 2 from India: Evidence for Reassortment between Outer Capsid Protein Genes.

Maan S, Maan NS, Belaganahalli MN, Kumar A, Batra K, Rao PP, Hemadri D, Reddy YN, Putty K, Krishnajyothi Y, Reddy GH, Singh KP, Hegde NR, Nomikou K, Sreenivasulu D, Mertens PP.

Genome Announc. 2015 Apr 9;3(2). pii: e00045-15. doi: 10.1128/genomeA.00045-15.

20.

Limit of detection of genomic DNA by conventional PCR for estimating the load of Staphylococcus aureus and Escherichia coli associated with bovine mastitis.

Chandrashekhar KM, Isloor S, Veeresh BH, Hegde R, Rathnamma D, Murag S, Veeregowda BM, Upendra HA, Hegde NR.

Folia Microbiol (Praha). 2015 Nov;60(6):465-72. doi: 10.1007/s12223-015-0384-0. Epub 2015 Mar 15.

PMID:
25773783
21.

A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains.

Singh A, Mitra M, Sampath G, Venugopal P, Rao JV, Krishnamurthy B, Gupta MK, Sri Krishna S, Sudhakar B, Rao NB, Kaushik Y, Gopinathan K, Hegde NR, Gore MM, Krishna Mohan V, Ella KM.

J Infect Dis. 2015 Sep 1;212(5):715-25. doi: 10.1093/infdis/jiv023. Epub 2015 Jan 18.

PMID:
25601942
22.

Molecular Typing of Bluetongue Viruses Isolated Over a Decade in South India.

Reddy YV, Krishnajyothi Y, Susmitha B, Devi BV, Brundavanam Y, Gollapalli SR, Karunasri N, Sonali B, Kavitha K, Patil SR, Sunitha G, Putty K, Reddy GH, Reddy YN, Hegde NR, Rao PP.

Transbound Emerg Dis. 2016 Oct;63(5):e412-8. doi: 10.1111/tbed.12320. Epub 2015 Jan 19.

PMID:
25598289
23.

Epidemiology of Bluetongue in India.

Rao PP, Hegde NR, Reddy YN, Krishnajyothi Y, Reddy YV, Susmitha B, Gollapalli SR, Putty K, Reddy GH.

Transbound Emerg Dis. 2016 Apr;63(2):e151-64. doi: 10.1111/tbed.12258. Epub 2014 Aug 28. Review.

PMID:
25164573
24.

Draft Genome Sequence of the Field Isolate Brucella melitensis Strain Bm IND1 from India.

Rao SB, Gupta VK, Kumar M, Hegde NR, Splitter GA, Reddanna P, Radhakrishnan GK.

Genome Announc. 2014 May 29;2(3). pii: e00497-14. doi: 10.1128/genomeA.00497-14.

25.
26.

Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India.

Hegde NR, Kumar D, Rao PP, Kumari PK, Kaushik Y, Ravikrishnan R, Prasad SD, Ella KM.

Vaccine. 2014 Jun 17;32(29):3636-43. doi: 10.1016/j.vaccine.2014.04.072. Epub 2014 May 5.

PMID:
24801052
27.

Type-specific seroprevalence of bluetongue in Andhra Pradesh, India, during 2005-2009.

Sairaju V, Susmitha B, Rao PP, Hegde NR, Meena K, Reddy YN.

Indian J Virol. 2013 Dec;24(3):394-7. doi: 10.1007/s13337-013-0156-x. Epub 2013 Aug 23.

28.

Comparative immunogenicity of two peste des petitis ruminants (PPR) vaccines in South Indian sheep and goats under field conditions.

Santhosh AK, Gomes AR, Hegde R, Rathnamma D, Veeregowda BM, Byregowda SM, Renukaprasad C, Bhanuprakash V, Prabhudas K, Hegde NR, Isloor S.

Indian J Virol. 2013 Dec;24(3):373-9. doi: 10.1007/s13337-013-0168-6. Epub 2013 Oct 11.

29.

Incidence of subclinical mastitis and prevalence of major mastitis pathogens in organized farms and unorganized sectors.

Hegde R, Isloor S, Prabhu KN, Shome BR, Rathnamma D, Suryanarayana VV, Yatiraj S, Prasad CR, Krishnaveni N, Sundareshan S, Akhila DS, Gomes AR, Hegde NR.

Indian J Microbiol. 2013 Sep;53(3):315-20. doi: 10.1007/s12088-012-0336-1. Epub 2012 Nov 23.

30.

Isolation and Complete Genome Sequencing of Bluetongue Virus Serotype 12 from India.

Rao PP, Reddy YV, Hegde NR.

Transbound Emerg Dis. 2015 Oct;62(5):e52-9. doi: 10.1111/tbed.12199. Epub 2013 Dec 11.

PMID:
24330644
31.

Deep sequencing as a method of typing bluetongue virus isolates.

Rao PP, Reddy YN, Ganesh K, Nair SG, Niranjan V, Hegde NR.

J Virol Methods. 2013 Nov;193(2):314-9. doi: 10.1016/j.jviromet.2013.06.033. Epub 2013 Jul 4.

PMID:
23831448
32.

Differentiation of Staphylococcus aureus and Staphylococcus epidermidis by PCR for the fibrinogen binding protein gene.

Sunagar R, Deore SN, Deshpande PV, Rizwan A, Sannejal AD, Sundareshan S, Rawool DB, Barbuddhe SB, Jhala MK, Bannalikar AS, Mugalikar DM, Kumari VJ, Dhanalakshmi K, Reddy YN, Rao PP, Babra C, Tiwari JG, Mukkur TK, Costantino P, Wetherall JD, Isloor S, Hegde NR.

J Dairy Sci. 2013 May;96(5):2857-65. doi: 10.3168/jds.2012-5862. Epub 2013 Mar 8.

33.

The persistence of biofilm-associated antibiotic resistance of Staphylococcus aureus isolated from clinical bovine mastitis cases in Australia.

Babra C, Tiwari JG, Pier G, Thein TH, Sunagar R, Sundareshan S, Isloor S, Hegde NR, de Wet S, Deighton M, Gibson J, Costantino P, Wetherall J, Mukkur T.

Folia Microbiol (Praha). 2013 Nov;58(6):469-74. doi: 10.1007/s12223-013-0232-z. Epub 2013 Feb 28.

PMID:
23446489
34.

Intercontinental movement of bluetongue virus and potential consequences to trade.

Rao PP, Hegde NR, Reddy YN.

J Virol. 2012 Aug;86(15):8341; author reply 8342-3. doi: 10.1128/JVI.00968-12. No abstract available.

35.

Complete genome sequence of bluetongue virus serotype 9: implications for serotyping.

Rao PP, Reddy YN, Hegde NR.

J Virol. 2012 Aug;86(15):8333. doi: 10.1128/JVI.01101-12.

36.

Evidence of bluetongue virus serotype 21 (BTV-21) divergence.

Susmitha B, Sudheer D, Rao PP, Uma M, Prasad G, Minakshi P, Hegde NR, Reddy YN.

Virus Genes. 2012 Jun;44(3):466-9. doi: 10.1007/s11262-012-0724-y. Epub 2012 Feb 18.

PMID:
22350945
37.

Genetic characterization of bluetongue virus serotype 9 isolates from India.

Rao PP, Reddy YV, Meena K, Karunasree N, Susmitha B, Uma M, Prasad PU, Chaitanya P, Reddy YN, Hegde NR.

Virus Genes. 2012 Apr;44(2):286-94. doi: 10.1007/s11262-011-0707-4. Epub 2012 Jan 19.

PMID:
22258368
38.

Use of PCR-based assays for the detection of the adventitious agent porcine circovirus type 1 (PCV1) in vaccines, and for confirming the identity of cell substrates and viruses used in vaccine production.

Kumar D, Beach NM, Meng XJ, Hegde NR.

J Virol Methods. 2012 Jan;179(1):201-11. doi: 10.1016/j.jviromet.2011.10.017. Epub 2011 Nov 3.

PMID:
22079617
39.

Sequences of genes encoding type-specific and group-specific antigens of an Indian isolate of bluetongue virus serotype 10 (BTV-10) and implications for their origin.

Gollapalli SR, Mallavarapu S, Uma M, Rao PP, Susmitha B, Prasad PU, Chaitanya P, Prasad G, Hegde NR, Reddy YN.

Transbound Emerg Dis. 2012 Apr;59(2):165-72. doi: 10.1111/j.1865-1682.2011.01266.x. Epub 2011 Oct 28.

PMID:
22032621
40.

Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination.

Hegde NR, Kaveri SV, Bayry J.

Drug Discov Today. 2011 Dec;16(23-24):1061-8. doi: 10.1016/j.drudis.2011.07.004. Epub 2011 Jul 18. Review.

PMID:
21782969
41.

Immunotherapy of viral infections.

Hegde NR, Rao PP, Bayry J, Kaveri SV.

Immunotherapy. 2009 Jul;1(4):691-711. doi: 10.2217/imt.09.26. Review.

PMID:
20635993
42.

Reasons to include viruses in the tree of life.

Hegde NR, Maddur MS, Kaveri SV, Bayry J.

Nat Rev Microbiol. 2009 Aug;7(8):615; author reply 615. doi: 10.1038/nrmicro2108-c1. No abstract available.

PMID:
19561628
43.

Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus.

Safronetz D, Hegde NR, Ebihara H, Denton M, Kobinger GP, St Jeor S, Feldmann H, Johnson DC.

J Virol. 2009 Jul;83(14):7285-95. doi: 10.1128/JVI.00373-09. Epub 2009 Apr 29.

44.

Thermostable foot-and-mouth disease virus as a vaccine candidate for endemic countries: a perspective.

Hegde NR, Maddur MS, Rao PP, Kaveri SV, Bayry J.

Vaccine. 2009 Apr 6;27(16):2199-201. doi: 10.1016/j.vaccine.2009.01.032. Epub 2009 Feb 2. No abstract available.

PMID:
19189856
45.

The role of BiP in endoplasmic reticulum-associated degradation of major histocompatibility complex class I heavy chain induced by cytomegalovirus proteins.

Hegde NR, Chevalier MS, Wisner TW, Denton MC, Shire K, Frappier L, Johnson DC.

J Biol Chem. 2006 Jul 28;281(30):20910-9. Epub 2006 May 25.

46.

Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL.

Hegde NR, Dunn C, Lewinsohn DM, Jarvis MA, Nelson JA, Johnson DC.

J Exp Med. 2005 Oct 17;202(8):1109-19. Epub 2005 Oct 10.

47.

A seek-and-hide game between Cd1-restricted T cells and herpesviruses.

Hegde NR, Johnson DC.

J Clin Invest. 2005 May;115(5):1146-9.

49.

T cell epitope identification for bovine vaccines: an epitope mapping method for BoLA A-11.

De Groot AS, Nene V, Hegde NR, Srikumaran S, Rayner J, Martin W.

Int J Parasitol. 2003 May;33(5-6):641-53. Review.

PMID:
12782061
50.

Viral inhibition of MHC class II antigen presentation.

Hegde NR, Chevalier MS, Johnson DC.

Trends Immunol. 2003 May;24(5):278-85. Review. No abstract available.

PMID:
12738423

Supplemental Content

Loading ...
Support Center